HTB: no. 6 (1 June 2022) PDF downloads
1 June 2022. Related: PDFs.
2022
Family of Greek activist Zak Kostopoulos decry minimal sentence given to his killers
5 May 2022. Related: Other news.
HTB May 2022 (2 May 2022)
2 May 2022. Related: Editorial.
29th Conference on Retroviruses and Opportunistic Infections (CROI 2022): third reports
2 May 2022. Related: Conference reports.
CROI 2022: Dolutegravir plus recycled tenofovir rather than switch to AZT: public health approach to second-line ART
2 May 2022. Related: Conference reports, Antiretrovirals, Treatment strategies.
CROI 2022: Other COVID-19 studies
2 May 2022. Related: Conference reports, Coinfections and complications, COVID-19.
FDA approves dispersible dolutegravir/abacavir/3TC for children
2 May 2022. Related: Antiretrovirals.
Access to ibalizumab uncertain in Europe: TaiMed looking for new partner after Thera quits
2 May 2022. Related: Antiretrovirals, Treatment access.
Asymptomatic COVID-19 is common in people living with HIV
2 May 2022. Related: Coinfections and complications, COVID-19: HIV and COVID-19 coinfection, COVID-19.
Longest COVID-19 infection lasted 505 days in an immunocompromised person in London
2 May 2022. Related: Coinfections and complications, COVID-19: HIV and COVID-19 coinfection, COVID-19: pathogenesis, COVID-19.
Herd immunity unlikely to control COVID-19: opinion article from US NIAID
2 May 2022. Related: Coinfections and complications, COVID-19: transmission & prevention, COVID-19.
The challenges of prioritising access to molnupiravir and nirmatrelvir–ritonavir for COVID-19
2 May 2022. Related: Coinfections and complications, COVID-19: complications, COVID-19.
Increased risk of blood clots after COVID-19: higher with underlying conditions and more severe symptoms
2 May 2022. Related: Coinfections and complications, COVID-19: complications, COVID-19.
Two new platform vaccines against COVID-19 report phase 3 results
2 May 2022. Related: Coinfections and complications, Other news, COVID-19: vaccine research, COVID-19.
A&E adopts opt-out HIV testing in London, Manchester, Salford and Brighton
2 May 2022. Related: HIV prevention and transmission.
Zimbabwe decriminalises HIV transmission
2 May 2022. Related: HIV prevention and transmission, Other news.
Community webinar series on HIV cure-related cell and gene therapy
2 May 2022. Related: Cure-related research.
HTB: no. 5 (2 May 2022) PDF downloads
2 May 2022. Related: PDFs.
HTB April 2022 (1 April 2022)
1 April 2022. Related: Editorial.
29th Conference on Retroviruses and Opportunistic Infections (CROI 2022): second reports
1 April 2022. Related: Conference reports.
CROI 2022: Webcasts now online and open access
1 April 2022. Related: Conference reports.
CROI 2022: Islatravir studies for HIV treatment and PrEP
1 April 2022. Related: Conference reports, Antiretrovirals.
CROI 2022: UK study reports diabetes mellitus in 9% of HIV positive Africans in the UK on stable ART
1 April 2022. Related: Conference reports, Coinfections and complications.
CROI 2022: Life expectancy reduced by eight years following hospitalisation for a mental health condition in South Africa
1 April 2022. Related: Conference reports, Coinfections and complications.
CROI 2022: Long COVID persists for over a year: evidence for divergent immune responses
1 April 2022. Related: Conference reports, Coinfections and complications, COVID-19: long COVID, COVID-19.
CROI 2022: Risk factors for NAFLD and proteinuria in HIV positive people on ART in the REPRIEVE study
1 April 2022. Related: Conference reports, Coinfections and complications.
CROI 2022: UK study shows PEP is started earlier using home starter packs
1 April 2022. Related: Conference reports, HIV prevention and transmission.
CROI 2022: Summary of 14 key studies on HIV and liver disease
1 April 2022. Related: Conference reports, Hepatitis coinfection.
CROI 2022: Genomic entrapment of HIV in people on long-term ART, chimeric antigen receptor T cells and more on bNAbs
1 April 2022. Related: Conference reports, Cure-related research.
US FDA removes need for oral lead-in with long-acting cabotegravir/rilpivirine injections: indication expanded to adolescents
1 April 2022. Related: Antiretrovirals.
HIV vaccine study using mRNA technology starts in the US
1 April 2022. Related: HIV prevention and transmission.
South Africa approves dapivirine vaginal ring for HIV prevention
1 April 2022. Related: HIV prevention and transmission.
BHIVA statement on fourth vaccine dose for people living with HIV in the UK
1 April 2022. Related: COVID-19: HIV and COVID-19 coinfection.
Temporary protection against omicron needs mRNA booster: limited data for those at highest risk
1 April 2022. Related: COVID-19: vaccine research, COVID-19.
HTB: no. 4 (1 April 2022) PDF downloads
1 April 2022. Related: PDFs.
Efficacy of mRNA vaccines in people with HIV or solid transplant recipients
8 March 2022. Related: COVID-19: vaccine research, COVID-19.
HTB March 2022 (1 March 2022)
1 March 2022. Related: Editorial.
EACS statement on the war in Ukraine
1 March 2022. Related: Editorial, Special reports.
Organisations to support the crisis in Ukraine
1 March 2022. Related: Editorial, Special reports.
29th Conference on Retroviruses on Opportunistic Infections (CROI 2022): First reports
1 March 2022. Related: Conference reports.
CROI 2022: Biktarvy (B/F/TAF): 5-year follow-up in two phase 3 studies
1 March 2022. Related: Conference reports, Antiretrovirals.
CROI 2022: Injectable CAB/RPV-LA results after three years follow-up
1 March 2022. Related: Conference reports, Antiretrovirals.
CROI 2022: Lenacapavir: 54 week results in treatment-naive participants of CALIBRATE study
1 March 2022. Related: Conference reports, Antiretrovirals.
CROI 2022: Lenacapavir in treatment-experienced participants, and as PrEP in macaques
1 March 2022. Related: Conference reports, Antiretrovirals.
CROI 2022: Fourth potential stem cell HIV cure – in a US woman using donor cord cells
1 March 2022. Related: Conference reports, Cure-related research.
CROI 2022: Strategies to suppress viral load off-ART with 3BNC117, 10-1074 and other bNAbs
1 March 2022. Related: Conference reports, Cure-related research.
CROI 2022: Targetting reservoir with ART + bNAb 3BNC117 + romidepsin maintained undetectable viral load off-ART for 3.7 years in one case
1 March 2022. Related: Conference reports, Cure-related research.
CROI 2022: Dual bNAb treatment maintains undetectable viral load off-ART in 44% of children in the Tatelo Study
1 March 2022. Related: Conference reports, Paediatric care, Cure-related research.
CROI 2022: AAV8-VRC07 vaccine generates new bNAb production in HIV positive people for up to three years
1 March 2022. Related: Conference reports, Cure-related research.
CROI 2022: No impact from high-dose vitamin D3 on reducing the HIV viral reservoir
1 March 2022. Related: Conference reports, Cure-related research.
CROI 2022: Higher maternal mortality and adverse birth outcomes among women with COVID-19 in Botswana
1 March 2022. Related: Conference reports, Women's health, Pregnancy.
CROI 2022: ANCHOR study reduces anal cancer by 57% and supports screening for people living with HIV
1 March 2022. Related: Conference reports, Cancer and HIV.
CROI 2022: Other studies on anal cancer
1 March 2022. Related: Conference reports, Cancer and HIV.
CROI 2022: Telomere shortening associated with TAF but not TDF in CHARTER study
1 March 2022. Related: Conference reports, Basic science and immunology, Ageing and life expectancy.
CROI 2022: Injectable PrEP: impressive results, new viral load monitoring – but price questions access
1 March 2022. Related: Conference reports, HIV prevention and transmission.
CROI 2022: Long-acting doravirine implants as PrEP to prevent vaginal HIV transmission in mouse study
1 March 2022. Related: Conference reports, HIV prevention and transmission.
CROI 2022: LEAP Workshop online: research into long-acting drugs
1 March 2022. Related: Conference reports, On the web.
Robert Carr Research Award: call for nominations
1 March 2022. Related: Other news.
Timing of menopause: experiences of women in Swiss HIV Cohort
1 March 2022. Related: Coinfections and complications, Ageing and life expectancy.
Long COVID may be more common in people living with HIV
1 March 2022. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Major review finds little benefit of remdesivir in people hospitalised with COVID-19
1 March 2022. Related: COVID-19: investigational drugs, COVID-19.
Melatonin does not protect against SARS-CoV-2
1 March 2022. Related: COVID-19: transmission & prevention.
Resources on Long COVID
1 March 2022. Related: COVID-19: long COVID, COVID-19: on the web, COVID-19.
WHO webinars: COVID-19 Global Research and Innovation Forum
1 March 2022. Related: COVID-19: on the web, COVID-19.
HTB: no. 3 (1 March 2022) PDF downloads
1 March 2022. Related: PDFs.